Delivery Order SPE2DB20D7059-SPE2DB25FPTQ2
Award Date
11/4/24
Potential Completion Date
11/5/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award SPE2DB22D1106|SPE2DB25FDPM8 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,047.60 firm fixed price delivery order contract is for the supply of Azelastine 0.1% (137 MCG) Spray, 30 ML. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,612.40 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product, to support military healthcare programs. The award has an ultimate completion date of May 23, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $1,245.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Azelastine 0.1% (137 MCG) spray medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
The federal contract award SPE2DB20D2104|SPE2DB23FU64W was issued by the Defense Logistics Agency (DLA) to prime contractor Amerisourcebergen Drug Corp. The $1,236.67 firm fixed-price delivery order is for the supply of 4561655782 - AZELASTINE 0.1% (137 MCG) SPRY 30ML, with a performance period through August 1, 2023. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,380.72, is for the delivery of Azelastine 0.1% (137 MCG) Spry 30ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
This contract award (SPE2DB20D2104|SPE2DB22FS22R) is for the delivery of Azelastine 0.1% (137 MCG) nasal spray, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,005.24 and a performance period ending on March 29, 2022. The contract was not set aside for any specific business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of azelastine 0.1% (137 mcg) nasal spray, a pharmaceutical product. The contract has a ceiling value of $1,144.56 and an ultimate completion date of January 6, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,760.86, is for the delivery of AZELASTIN-FLUTIC 137-50MCG SPR 23GM, a pharmaceutical product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
The Defense Logistics Agency awarded a $97,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply 4562330639 units of 0.1% azelastine hydrochloride nasal spray solution to meet requirements under the agency's pharmaceutical prime vendor contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 27-28, 2023. No...
The Defense Logistics Agency awarded a $87,120 delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply approximately 137 milligrams of the 0.1% concentration nasal spray packaged in 30 milliliter bottles to the DLA. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 29th to 30th, 2023. The firm fixed price contract was awarded without...